Onderneming Mineralys Therapeutics, Inc.
Aandelen
MLYS
US6031701013
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,52 USD | -5,26% | +4,40% | +57,21% |
Vakgebied
Aantal werknemers: 28
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 60 | 01-11-20 |
Adam Levy
DFI | Director of Finance/CFO | 46 | 01-03-22 |
Jessica Ibbitson
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
David Rodman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-01-21 |
Minji Kim
PRN | Corporate Officer/Principal | - | 04/01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 01-02-21 | |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 13-09-23 |
Director/Board Member | 58 | 01-02-21 | |
Daphne Karydas
BRD | Director/Board Member | 49 | 13-09-23 |
Olivier Litzka
BRD | Director/Board Member | 56 | 08-05-22 |
Jon Congleton
CEO | Chief Executive Officer | 60 | 01-11-20 |
Derek DiRocco
BRD | Director/Board Member | 43 | 08-05-22 |
BT Slingsby
FOU | Founder | 47 | 31-05-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 49 648 540 | 42 994 512 ( 86,60 %) | 0 | 86,60 % |
Bedrijfsgegevens
Mineralys Therapeutics, Inc.
150 North Radnor Chester Road Suite F200
19087, Radnor
+
http://www.mineralystx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+57,21% | 671 mln. | |
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+48,77% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |
- Beurs
- Aandelen
- Koers MLYS
- Onderneming Mineralys Therapeutics, Inc.